Next Article in Journal
1,8-Dihydroxy Naphthalene—A New Building Block for the Self-Assembly with Boronic Acids and 4,4′-Bipyridine to Stable Host–Guest Complexes with Aromatic Hydrocarbons
Next Article in Special Issue
Therapeutic Applications of Essential Oils from Native and Cultivated Ecuadorian Plants: Cutaneous Candidiasis and Dermal Anti-Inflammatory Activity
Previous Article in Journal
Special Issue—“Isolation, Structure Elucidation and Biological Activity of Natural Products”
Previous Article in Special Issue
Comprehensive Quality Evaluation of Polygonatum cyrtonema and Its Processed Product: Chemical Fingerprinting, Determination and Bioactivity
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 28
Issue 14
10.3390/molecules28145393
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Medicinal Mushrooms: Their Bioactive Components, Nutritional Value and Application in Functional Food Production—A Review

by
Paulina Łysakowska
,
Aldona Sobota
* and
Anna Wirkijowska
Department of Plant Food Technology and Gastronomy, University of Life Sciences in Lublin, Skromna 8 Street, 20-704 Lublin, Poland
*
Author to whom correspondence should be addressed.
Molecules 2023, 28(14), 5393; https://doi.org/10.3390/molecules28145393
Submission received: 11 April 2023 / Revised: 11 July 2023 / Accepted: 11 July 2023 / Published: 14 July 2023
(This article belongs to the Special Issue Natural Bioactive Compounds and Human Health)
Versions Notes

Abstract

:
Medicinal mushrooms, e.g., Lion’s Mane (Hericium erinaceus (Bull.) Pers.), Reishi (Ganoderma lucidum (Curtis) P. Karst.), Chaga (Inonotus obliquus (Ach. ex Pers.) Pilát), Cordyceps (Ophiocordyceps sinensis (Berk.) G.H. Sung, J.M. Sung, Hywel-Jones and Spatafora), Shiitake (Lentinula edodes (Berk.) Pegler), and Turkey Tail (Trametes versicolor (L.) Lloyd), are considered new-generation foods and are of growing interest to consumers. They are characterised by a high content of biologically active compounds, including (1,3)(1,6)-β-d-glucans, which are classified as dietary fibre, triterpenes, phenolic compounds, and sterols. Thanks to their low-fat content, they are a low-calorie product and are classified as a functional food. They have a beneficial effect on the organism through the improvement of its overall health and nutritional level. The biologically active constituents contained in medicinal mushrooms exhibit anticancer, antioxidant, antidiabetic, and immunomodulatory effects. In addition, these mushrooms accelerate metabolism, help fight obesity, and slow down the ageing processes thanks to their high antioxidant activity. The vast therapeutic properties of mushrooms are still not fully understood. Detailed mechanisms of the effects of medicinal mushrooms on the human organism still require long-term clinical studies to confirm their nutraceutical effects, their safety of use, and their dosage. Medicinal mushrooms have great potential to be used in the design of innovative functional foods. There is a need for further research on the possibility of incorporating mushrooms into food products to assess the interactions of their bioactive substances with ingredients in the food matrix. This review focuses on the properties of selected medicinal mushrooms and their effects on the human organism and presents current knowledge on the possibilities of their use in the production of functional foods.

1. Introduction

For many years, mushrooms have accompanied humans both as food and medicine. Data from the literature indicate that, with the onset of hunting, mushrooms began to play an important role in the human diet [1]. Fruiting bodies, i.n., the visible part above the substrate commonly referred to as the mushroom, are the edible elements of some filamentous fungi [2]. Fungi form a separate kingdom alongside the kingdoms of prokaryotes, eukaryotes, plants, and animals [3]. About 2.2–3.8 million species of fungi in the world have been identified, of which 150,000 species have been described, 2000 species are considered edible, and over 200 species of wild mushrooms are considered medicinal [4,5]. Edible mushrooms, unlike medicinal mushrooms, are mainly consumed as fresh mushrooms with fruiting bodies or dried products. They can also be consumed as boiled, fried, roasted, soups, tinctures, teas, and many different dishes, while medicinal mushrooms are mostly used in biopharmaceutical applications in powdered, loose, or liquid extract forms [6]. In culinary terms, mushrooms are wrongly classified as vegetables and are informally categorised as ‘white vegetables’ [7]. According to the USDA (United States Department of Agriculture), they can be used as a substitute for vegetables in the diet at a ratio of 1:1 (USDA, 2022). Due to their content of biologically active compounds with beneficial health effects, medicinal mushrooms have been used worldwide in folk medicine for centuries. They are particularly popular in Asian countries, e.g., China, Japan, Taiwan, and Korea. Due to the presence of numerous biologically active compounds, including polysaccharides, proteins, peptides, terpenoids, polyphenols, vitamins, and mineral elements, they are ascribed, e.g., anti-cancer, anti-inflammatory, antioxidant, hypocholesterolemic, hypoglycaemic, and immunomodulatory effects [8,9] However, it should be remembered that the consumption of medicinal mushrooms is not always advisable. The safety of their use during pregnancy, lactation, and in children is still poorly reported. The selected bioactive compounds found in mushrooms may potentially limit the absorption of nutrients, trace elements, and vitamins. As a result, it is recommended that the elderly and children avoid the excessive consumption of mushrooms. Additionally, individuals taking medications or herbs should exercise caution when using mushrooms due to the potential for interactions with their bioactive compounds.
The chemical profile of medicinal mushrooms varies according to species, strain, cultivation conditions (cultured or growing wild) [10], the degree of maturity [11], and the proportion of individual anatomical parts in the total mass of the mushroom [12]. This is largely determined by environmental (access to water, light, UV radiation) [9,13] and biological (type of substrate/host, presence of competing fungi) factors. Song et al. [8] compared the chemical composition and functional properties of wood-cultured and sack-cultured Shiitake (Lentinula edodes (Berk.) Pegler) and proved that the wood-cultured fungus had a higher content of terpenoids and phenolic components and concurrently exhibited higher antioxidant and hypoglycaemic potential compared to the sack-cultured Shiitake (Lentinula edodes (Berk.) Pegler). In the case of Chaga (Inonotus obliquus (Ach. ex Pers.) Pilát), which is a parasite of various deciduous trees, only sclerotia derived from birch trunks have contained tree-specific compounds (betulin and betulinic acid) showing anticarcinogenic activity. Equally great importance for the chemical composition and health-promoting potential of medicinal mushrooms is ascribed to the world region from which they originate [14,15]. Chaga (Inonotus obliquus (Ach. ex Pers.) Pilát) sclerotia collected in France, Ukraine, and Canada were characterised by their different contents of betulin, betulinic acid, and inotodiol and showed differential biological activity in different cancer cells [15]. The bioactive substances present in fungi are primary and secondary metabolites that can be synthesised in response to specific environmental stimuli [9,13]. Their content depends on the species of fungus and their growing conditions [10,16]. However, Peng and Shahidi [17] emphasise that the cultivation of medicinal mushrooms in standard conditions offers the possibility to stimulate the synthesis of selected biologically active substances and yields raw materials with a reproducible chemical composition, comparable biological effects, and greater health safety (with a lower content of heavy metals, which are often found in excess in wild mushrooms growing in polluted environments).
The existence of a huge number of medicinal mushroom species with their diverse chemical composition and content of biologically active compounds and thus multidirectional effects on the human organism could make mushrooms objects of growing consumer interest. In 2020, the size of the global mushroom market was 14.35 million tonnes; it is estimated to grow to 24.05 million tonnes in 2028. The most popular mushrooms among consumers include Reishi (Ganoderma lucidum), Lion’s Mane (Hericium erinaceus), Chaga (Inonotus obliquus (Ach. ex Pers.) Pilát), Turkey Tail (Trametes versicolor (L.) Lloyd)), Shiitake (Lentinula edodes (Berk.) Pegler), and Cordyceps (Ophiocordyceps sinensis (Berk.) G.H. Sung, J.M. Sung, Hywel-Jones and Spataforaprior name Cordyceps sinensis). It is, therefore, expedient to compile and systematise existing knowledge on the most popular medicinal mushrooms, compare their functional potential, and discuss the possibilities of their use in the food industry.

2. Nutritional Value and Bioactive Components

Due to their high-water content (about 80–90%), the fruiting bodies of medicinal mushrooms are low in calories (50–70 kcal/100 g) [18]. After drying, their moisture content is at the level of about 3–13% [12,19,20]. The chemical composition of medicinal mushrooms is shown in Table 1. These mushrooms are a source of such nutrients as carbohydrates (65.6–87.13% d.b.), dietary fibre (16–53% d.b.), protein (3.87–37.4% d.b.), minerals (6.2–9.7% d.b.), and fats (1–5.62% d.b.) [21].

2.1. Polysaccharides

Carbohydrates present in fungi are represented by monosaccharides (glucose, fructose, galactose), alcohol sugars (mannitol), oligosaccharides (trehalose, malezitose), and polysaccharides, among which homopolysaccharides (glucans, chitin, glycogen) and heteropolysaccharides (xylomannan, α-(1→4)-d-glucopyranosyl and β-(1→6)-d-galactopyranosyl with branches at O-6 of glucose and O-2 of galactose, 6-O-galactopyranoses substituted at O-2 by 3-O-d-mannopyranosyl-L-fucopyranosyl, α-d-mannopyranosyl, and α-L-fucopyranosyl, α-(1→3)-linked galactose, with β-(1→4),(1→6)-glucose and fucose branches, mucilage composed of glucose and galactose can be distinguished). Carbohydrates can also occur in complexes with other compounds (e.g., proteins) and may include various sugar subunits [29,30,31]. Depending on their structure, bond type, and molecular weight, carbohydrates have different functional properties. The main indigestible polysaccharides present in fungi are chitin and β-d-glucans. They are composed of sugar units that are linked by β-glycosidic bonds. The monomer in chitin is β-glucosamine and is linked by 1-4-β-glycosidic bonds, while β-glucans are made up of glucopyranose molecules. The molecules linked by β-(1,3) and β-(1,4) glycosidic bonds form linear segments to which side chains are attached via β-(1,6) glycosidic bonds [29]. These compounds are classified as dietary fibres. They are found in fungal fruiting bodies and in fungal cells at both the vegetative and generative stages of ontogenesis and play a structural role in co-forming cell walls. A special physiological role is attributed to β-d-glucans and complexes of these compounds with proteins [32,33].
Their structure takes the form of a single helix, a triple helix, or a random helix. Depending on their molecular weight, the type of β-glycosidic bonds present in the molecule, and the chain conformation, these compounds exhibit different functional properties [34]. Beta-glucans with a triple helix structure show a greater ability to inhibit tumour growth than β-glucans in a single helix form [35]. As reported by Sletmoen and Stokke [36] and Brown and Gordon [37], compounds with a higher molecular weight and lower water solubility are more potent immunostimulators, while β-glucans with a low MW and a short side chain are considered less active. On the contrary, Rop et al. [34] found that water-soluble β-glucans had stronger immunomodulatory properties than water-insoluble β-glucans. Macrophages mainly act as antigen-presenting immune cells, which contribute to the immunomodulatory effect of β-glucans by stimulating the fight against bacteria and viruses. High molecular weight molecules stimulate the action of specific lymphocyte—NK cells, which show cytotoxic effects against tumour cells.
In addition, they upregulate the expression of cytokines that are associated with immune response, including interferon-γ, TNF-α, IFN-g, IL-1, and IL-12, which inhibit tumour cell proliferation and induce their apoptosis, thereby exerting anti-tumour, antibacterial, and antiviral effects [23,37,38]. These compounds are often used as adjuvants in traditional cancer chemotherapy [39,40,41,42,43,44].
The content of β-glucans in mushrooms varies between 3.79% d.b. for Cordyceps (Ophiocordyceps sinensis (Berk.) G.H. Sung, J.M. Sung, Hywel-Jones and Spatafora) and 60.79% d.b. for Turkey Tail (Trametes versicolor (L.) Lloyd) (Table 2) [44,45]. In general, edodes are a better source of these compounds than caps. The Shiitake (Lentinula edodes (Berk.) Pegler) mushroom is a rich source of β-glucans [34]. It takes its specific name from its β-glucan lentinan, which stimulates immune cells to attack cancer cells. Lentinan enhances the production of T lymphocytes and can potentiate the effect of AZT (3′-Azido-3′-deoxythymidine) in the anti-viral treatment of AIDS [27]. Its positive effects have been proved in the treatment of, e.g., glioma (human astrocytoma U251 cells) [46], breast cancer [47] and liver cancer [48]. In turn, the Turkey Tail (Trametes versicolor (L.) Lloyd) contains characteristic proteoglucans. One of these is crestin, also known as polysaccharide-K (PSK), which contains about 25–38% of the protein in the molecule. This proteoglucan is effective in the treatment of, e.g., gastric, oesophageal, colon, rectal, and lung cancer [29].
Another type of glucan that is complexed with protein present in Turkey Tail (Trametes versicolor (L.) Lloyd) mushrooms is called PSP (Poly Saccharo Peptide) and activates immune cells by increasing the production of cytokines, chemokines, histamine, and prostagladin E. It reduces the detrimental effects of chemotherapy by alleviating fatigue, loss of appetite, vomiting, a dry mouth, and other related discomforts [49]. In addition to β-glucans, biological activity has also been attributed to poly- and monosaccharides occurring in complexes with other compounds. An example is the cordycepin present in cordyceps (Ophiocordyceps sinensis (Berk.) G.H. Sung, J.M. Sung, Hywel-Jones, and Spatafora). Its chemical structure resembles that of the nucleoside adenosine (ribose + adenine sugar); however, it lacks one hydroxyl group at position three of the five-membered ring of the ribose moiety. Adenosine is involved in DNA and/or RNA synthesis in cells. Thanks to its analogy to adenosine, cordycepin can build into the RNA and DNA structures of bacteria and viruses and interfere with the biosynthesis and modification of nucleic acids, thereby limiting the growth of these microorganisms. It increases the proliferation and secretion of T and B lymphocytes and has anti-inflammatory effects through a reduction in the expression of pro-inflammatory cytokines and chemokines. Additionally, it inhibits platelet aggregation and shows suppressive properties against tumour cells [50]. The positive effects of polysaccharides as well as other phytochemicals present in mushrooms, are shown in Table 3.

2.2. Proteins

In addition to polysaccharides, proteins, and peptides are important bioactive components that are present in mushrooms. Their content ranges widely from 4.6 to 56.3 g/100 g and is mainly determined by the mushroom species. Of the mushrooms discussed, Lion’s Mane (Hericium erinaceus (Bull.) Pers.), Cordyceps (Ophiocordyceps sinensis (Berk.) G.H. Sung, J.M. Sung, Hywel-Jones and Spatafora), and Shiitake (Lentinula edodes (Berk.) Pegler) have the highest protein content (more than 20%) [23]. The amino acid composition and sequence and the length of the polypeptide chain can determine the specific biological activity of these compounds. They are most commonly ascribed to hypotensive, angiotensin-converting enzyme (ACE) inhibition, antioxidant, anticancer, antiviral, and antibacterial activities [63]. The most important bioactive fungal proteins include lectins (glycoproteins), immunomodulatory proteins, and proteins with enzymatic activity, e.g., nucleases, ribonucleases, laccase, and ergotionein [64]. Lectins increase insulin secretion and contribute to lowering blood sugar levels. In addition, they activate the immune system and show chemo-preventive effects against various types of cancer, e.g., hepatocellular carcinoma [65,66]. These compounds are present, e.g., in Reishi (Ganoderma lucidum). This type of protein, named TVC, was also isolated by Li et al. [67] from the fungus Trametes versicolor. As demonstrated by the authors, TVC increases the proliferation of human peripheral blood lymphocytes and is responsible for the increased necrosis of alpha tumour cells that are induced by mouse macrophages [67]. A characteristic low molecular weight peptide (cordymin) is present in cordyceps (Ophiocordyceps sinensis (Berk.) G.H. Sung, J.M. Sung, Hywel-Jones and Spatafora). Studies have demonstrated a protective role for this compound in lowering blood glucose levels in alloxan-induced hyperglycaemic rats. A dose of 50–100 mg/kg of the body weight of the animals also resulted in a reduction in aglycated haemoglobin (HbA11C) levels 5 weeks after the study. The oxidative stress induced by high sugar levels and the animal body weight decreased [68]. Numerous studies have shown that mushroom-derived protein has a complete amino acid profile. As highlighted by Thatoi and Singdevsachan [69], its nutritional value is even greater than that of milk, meat, or egg proteins. The protein present in mushrooms can be characterised by a high content of essential amino acids and glutamic acid, aspartic acid, or arginine. Pop et al. [70] reported that the tramates versicolor contained as many as 18 types of amino acids like aspartic acid, threonine, serine, glutamic acid, glycine, alanine, valine, and leucine, which were identified. Furthermore, studies have confirmed the presence of ornithine, which is known for its particular physiological activity, and the non-protein neurotransmitter γ-aminobutyric acid (GABA) [71].

2.3. Lipids

The fat content in mushrooms varies depending on the species but can range from 0.1 to 5.9 g/100 g [19]. Among medicinal mushrooms, Cordyceps (Ophiocordyceps sinensis (Berk.) G.H. Sung, J.M. Sung, Hywel-Jones, and Spatafora) and Shiitake (Lentinula edodes (Berk.) Pegler) are the most abundant in fat. About 52–87% of the fat is made up of unsaturated fatty acids (UFAs) such as oleic (C18:1) and linoleic (C18:2) acids [1,25,71,72]. These acids predominate, for example, in Cordyceps (Ophiocordyceps sinensis (Berk.) G.H. Sung, J.M. Sung, Hywel-Jones and Spatafora). The minor fatty acid in this mushroom is saturated fatty acids, e.g., palmitic (C16:0) and stearic (C18:0) acids. Guo et al. [72] found that the fatty acid profile could vary depending on geographical origin in the example of cordyceps (Ophiocordyceps sinensis (Berk.) G.H. Sung, J.M. Sung, Hywel-Jones and Spatafora).
Comparative examinations between indoor-cultivated and wild Ophiocordyceps sinensis (Berk.) G.H. Sung, J.M. Sung, Hywel-Jones, and Spatafora, conducted by Guo et al. [72], demonstrated that the wild mushrooms were characterized by a higher PUFAs (Polyunsaturated Fatty Acids) content with indoor-cultivated mushrooms. Such fatty acids as oleic acid, hydroxydocosanoic acid, hydroxytricosanoic acid, hydroxytetracosanoic acid, and hydroxypentacosanoic acid are predominate in Shiitake (Lentinula edodes (Berk.) Pegler) mushrooms. Stearic acid, hydroxyhexacosanoic acid, linoleic acid, palmitic acid, hydroxyarachidic acid, hydroxyheneicosanoic acid, and hydroxy-tricosenoic acid are present in smaller amounts [17].
Linoleic acid is known to have anticancer effects on breast, colon, and prostate cancer; thus, as a natural source of this acid, medicinal mushrooms also exhibit such properties [73]. Furthermore, unsaturated fatty acids can be used for the production of tissue hormones and are useful in preventing excessive blood clotting.

2.4. Sterols

Mushrooms are also a source of sterols classified as bioactive compounds. The most common of these is ergosterol. This compound undergoes photolysis to vitamin D2 when exposed to UV radiation [74]. A study conducted by Zheng et al. [75] showed that ergosterol exhibited cytotoxicity towards acute promyelocytic leukaemia cancer cells and liver cancer cells. At the same time, the authors noted moderate antimicrobial activity against selected bacteria and fungi. A characteristic sterol named H1-A, which resembles testosterone and dehydroepiandrosterone in its structure, was isolated from Cordyceps. In vivo studies in mice have shown that this compound could be effective for the treatment of selected autoimmune diseases [76].

2.5. Polyphenols

Thanks to the presence of polyphenols, including mainly phenolic acids represented by benzoic acid and cinnamic acid derivatives, medicinal mushrooms can be attributed to antioxidant activity. As reported by Ahmed et al. [77], gallic, caffeic, and p-coumaric acids are the predominant phenolic compounds in mushrooms. Phenolic compounds that are present in mushrooms exhibit strong antioxidant properties [78]. They inhibit free radicals and limit peroxide decomposition, scavenge reactive oxygen species, and block the action of metals when catalysing oxidation reactions [79,80,81]. Thus, they prevent mutations of cellular DNA and reduce the processes of carcinogenesis [82]. Peng and Shahidi [17] analysed Chaga ethanol extracts and detected 111 different phenolic compounds, including phenolic acids, flavonoids, coumarins, quinones, and styrylpyrones. Flavonoids in medicinal mushrooms are represented by myricetin, rutin, naringenin, quercetin, morin, and hesperetin [83]. Research conducted by Sharpe et al. [78] showed that, among many medicinal mushrooms, Chaga (Inonotus obliquus (Ach. Ex Pers.) Pilát) had the highest polyphenolic content and the highest antioxidant activity. The total phenolic content in this mushroom was at 97 µmol GAE/mg, while the content in reishi (Ganoderma lucidum (Curtis) P. Karst.), shiitake, and turkey tail (Trametes versicolor (L.) Lloyd) was 21, 13, and 0.1 µmol GAE/mg, respectively. The water-ethanol extract from Chaga (Inonotus obliquus (Ach. Ex Pers.) Pilát) exhibited approximately five times higher antioxidant activity against DPPH than other mushrooms. Mushroom polyphenols exhibit multidirectional beneficial effects on the human body: anticancer, antioxidant, hypoglycemic, slowing down the aging process, and preventing the degenerative diseases of the nervous system and cardiovascular diseases. When used as a food additive, they reduce fat oxidation processes and extend the shelf life of products [79].

2.6. Terpenes and Terpenoids

Another group of compounds includes terpenes, with the general formula (C5H8)n, and terpenoids containing additional functional groups (-OH, -CHO, =CO, -COOH, -O-O-). Triterpenes are the main biologically active metabolites of terpenoid nature and are synthesized by Ganoderma lucidum (Curtis) P. Karst. and Inonotus obliquus (Ach. ex Pers.) Pilát. Data in the literature have reported that large amounts of these compounds, e.g., in reishi (Ganoderma lucidum (Curtis) P. Karst.) and chaga (Inonotus obliquus (Ach. ex Pers.) Pilát). Terpenes exert primarily anti-inflammatory effects. Triterpenes isolated from Ganoderma lucidum (Curtis) P. Karst. and Inonotus obliquus (Ach. ex Pers.) Pilát reduced the secretion of pro-inflammatory cytokines in macrophages (such as TNF-α, IL-1β, and IL-6) and the inflammatory mediators of nitric oxide (NO) and prostaglandin E2 (PGE2) [84,85]. Similarly, anti-inflammatory properties were exhibited by lanostane-type triterpene acids present in Ganoderma lucidum (Curtis) P. Karst., which, as shown by Akihisa et al. [85], inhibited the inflammatory process induced in mouse macrophages. In addition to anticholinesterase activity, the beneficial effects of mushroom terpenes have been reported in anticancer, antiviral, antimalarial, and antimalarial treatments [86,87]. The pharmacological effect of triterpenoids has been employed in the treatment of neurodegenerative diseases, including Alzheimer’s disease [88].

2.7. Vitamins and Minerals

The nutritional value of medicinal mushrooms is also related to their high vitamin and micronutrient content. The vitamins present in mushrooms are mainly fat-soluble vitamins, including A and E. as well as vitamin D2 (ergocalciferol) and provitamin D2 (ergosterol). Interestingly, medicinal mushrooms are considered to be the only non-animal raw material that contains vitamin D [27,89]. Thanks to their tocopherol content, medicinal mushrooms exhibit antioxidant properties [89]. In addition, medicinal mushrooms are a very good source of water-soluble B vitamins (B1, B2, B3, B6, B9, B12) and vitamin C [19]. The vitamin B12 found in medicinal mushrooms was an analogue of that found in beef, fish, and liver, indicating its highly bioavailable. Therefore, mushrooms can be a valuable addition to vegetarian and vegan diets [90,91]. Shitake is rich in vitamins that exhibit antioxidant properties such as A, E, and C [27]. Medicinal mushrooms are rich in valuable mineral elements, including K, P, Na, Ca, and Mg, and, in smaller amounts, Cu, Zn, Fe, Mo, and Cd [27,79]. Given the ability of fungi to accumulate such heavy metals as Cd, Pb, Ar, Cu, Ni, Ag, Cr, and Hg, it is important that they grow in the least contaminated environment possible [92].

3. Possibilities of Using Medicinal Mushrooms for Functional Food Production

Medicinal mushrooms and mushroom-derived preparations containing bioactive compounds are classified as nutraceuticals. According to the European Food Safety Agency, they can be used as supplements due to their health-promoting and disease-preventing activity [93]. The production of nutraceuticals requires a great deal of knowledge of the functional properties of individual mushroom species. Due to the possible presence of substances that are harmful to health, it is necessary to control the origin, cultivation conditions, and raw material processing in order to ensure the health and safety of nutraceutical products on the one hand and an adequate level of biologically active compounds on the other to guarantee the beneficial effects of its preparation on health [94]. Clinical studies have shown that the recommended dose of nutraceutical preparations varies depending on the diagnosis and the patient [95]. Currently, a variety of fungal preparations are commercially available, most commonly in the dry extract form. There is growing interest in exploring the possibility of using various medicinal mushroom preparations to develop functional foods. An example of a popular product with medicinal mushrooms such as Chaga (Inonotus obliquus (Ach. ex Pers.) Pilát), cordyceps (Ophiocordyceps sinensis (Berk.) G.H. Sung, J.M. Sung, Hywel-Jones & Spatafora), shiitake, lion’s mane (Hericium erinaceus (Bull.) Pers.) or reishi (Ganoderma lucidum (Curtis) P. Karst.) is coffee. Its consumption regulates blood pressure, prevents heartburn, stimulates mental performance, boosts energy, and strengthens the immune system and performance of the organism [96]. Some medicinal mushrooms have also been used to enrich cereals, meat, fish, and beverage products (Table 4). Of the mushrooms discussed so far, reishi (Ganoderma lucidum (Curtis) P. Karst.) and shiitake (Lentinula edodes (Berk.) Pegler) have been used most commonly. In all food products, the addition of dried and powdered mushrooms resulted in an increase in protein and the total and insoluble dietary fibre and significantly increased the micronutrient content [66]. The introduction of mushroom powder at 5% in such bakery products as bread and biscuits did not have adverse effects of their quality [97]. In the case of additions above 5%, a deterioration in texture was often noted not only in bread but also in pasta, yoghurt, and cured meats (Table 4). There is no information in the literature on the possibility of using turkey tail (Trametes versicolor (L.) Lloyd), cordyceps (Ophiocordyceps sinensis (Berk.) G.H. Sung, J.M. Sung, Hywel-Jones and Spatafora), lion’s mane (Hericium erinaceus (Bull.) Pers.), or Chaga (Inonotus obliquus (Ach. ex Pers.) Pilát) preparations for food enrichment. Given the high health-promoting potential of these mushrooms, further research into the possibility of developing new functional foods with the above-mentioned mushrooms is advisable. The effect on the addition of selected medicinal mushrooms on quality parameters and the chemical composition of food products is presented in Table 4. An important issue in the design and implementation of new food products is sensory quality. Scientific studies have shown that the addition of medicinal mushrooms to foods, especially in a crushed or powdered form, can have a negative effect on the taste, texture, flavour, colour, and appearance of products. The addition of alcoholic or aqueous mushroom extracts has a less negative impact on the sensory quality and, with a small amount (up to 4%), can even improve the selected sensory characteristics of products.

4. Conclusions or Concluding Remarks

To date, a great deal of research has already been conducted into medicinal mushrooms; however, given the diversity of species and the amount of bioactive substances contained therein, this area still appears to be incompletely explored. It seems advisable to conduct research not only to isolate and identify the bioactive substances present in mushrooms but also to conduct clinical experiments to confirm the therapeutic effect of these substances. Such studies could facilitate a determination of the dose and duration of use for mushroom nutraceuticals. Toxicological studies confirming the safety of medicinal mushrooms are also needed. In the context of using medicinal mushrooms for the development of functional foods, it is important to study the interactions between the biologically active compounds present in mushrooms and food ingredients. It is important to bear in mind that the components present in the food matrix may act synergistically or antagonistically with mycochemicals, increasing or reducing their beneficial physiological effects, respectively. Based on the analysis of available information and scientific research, it can be concluded that the addition of medicinal mushrooms to foods, especially cereal products, can make their chemical composition more attractive due to their great health-promoting properties and the presence of biologically active compounds. Medicinal mushrooms are known for their potential to improve immunity, regulate metabolism, and prevent many diseases. The abundance of polysaccharides, polyphenols, amino acids, and vitamins in medicinal mushrooms is a valuable source of biologically active compounds that can contribute to maintaining the health and well-being of the body. At the same time, further scientific research is needed to confirm these benefits and develop optimal methods for the addition of medicinal mushrooms to foods, taking into account technological, sensory, and food safety aspects.

Funding

This research was supported by project no. SD/54/TŻ/2022 provided by the University of Life Sciences in Lublin, Poland.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data sharing not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Wani, A.; Bodha, R.H.; Wani, A.H. Nutritional and medicinal importance of mushrooms. J. Med. Plants Res. 2010, 4, 2598–2604. [Google Scholar] [CrossRef] [Green Version]
  2. Feeney, M.J.; Miller, A.M.; Roupas, P. Mushrooms-Biologically Distinct and Nutritionally Unique: Exploring a ”Third Food Kingdom”. Nutr. Today 2014, 49, 301–307. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Verma, A.K.; Prakash, S. Status of Animal Phyla in Different Kingdom Systems of Biological Classification. Int. J. Biol. Innov. 2020, 2, 149–154. [Google Scholar] [CrossRef]
  4. Beulah, H.; Margret, A.A.; Nelson, J. Marvelous Medicinal Mushrooms. Int. J. Pharma Bio Sci. 2013, 3, 611–615. [Google Scholar]
  5. Hyde, K.D. The numbers of fungi. Fungal Divers. 2022, 114, 1. [Google Scholar] [CrossRef]
  6. Elkhateeb, W.A.; Daba, G.M.; Thomas, P.W.; Wen, T.-C. Medicinal Mushrooms as a Source of Natural Therapeutic Bioactive Compounds. Egypt. Pharm. J. 2019, 18, 145–155. [Google Scholar] [CrossRef]
  7. Weaver, C.; Marr, E.T. White vegetables: A forgotten source of nutrients: Purdue roundtable executive summary. Adv. Nutr. 2013, 4, 318–326. [Google Scholar] [CrossRef] [Green Version]
  8. Song, T.; Zhang, Z.; Liu, S.; Chen, J.; Cai, W. Effect of Cultured Substrates on the Chemical Composition and Biological Activities of Lingzhi or Reishi Medicinal Mushroom, Ganoderma lucidum (Agaricomycetes). Int. J. Med. Mushrooms 2020, 22, 1183–1190. [Google Scholar] [CrossRef] [PubMed]
  9. Elkhateeb, W.A.; Daba, G.M. Medicinal mushroom: What should we know? Int. J. Pharm. Chem. Anal. 2022, 9, 1–9. [Google Scholar] [CrossRef]
  10. Cateni, F.; Gargano, M.L.; Procida, G.; Venturella, G.; Cirlincione, F.; Ferraro, V. Mycochemicals in wild and cultivated mushrooms: Nutrition and health. Phytochem. Rev. 2022, 21, 339–383. [Google Scholar] [CrossRef]
  11. Barros, L.; Baptista, P.; Estevinho, L.M.; Ferreira, I.C.F.R. Effect of Fruiting Body Maturity Stage on Chemical Composition and Antimicrobial Activity of Lactarius sp. Mushrooms. J. Agric. Food Chem. 2007, 55, 8766–8771. [Google Scholar] [CrossRef]
  12. Safin, R.R.; Gainullin, R.H.; Safina, A.V.; Gainullin, R.H. Methods for evaluating chaga extraction effectiveness based on its porosity change. J. Phys. Conf. Ser. 2022, 2373, 042007. [Google Scholar] [CrossRef]
  13. Huang, G.; Cai, W.; Xu, B. Vitamin D2, Ergosterol, and Vitamin B2 Content in Commercially Dried Mushrooms Marketed in China and Increased Vitamin D2 Content Following UV-C Irradiation. Int. J. Vitam. Nutr. Res. 2017, 87, 237–246. [Google Scholar] [CrossRef] [PubMed]
  14. Glamočlija, J.; Ćirić, A.; Nikolić, M.; Fernandes, Â.; Barros, L.; Calhelha, R.C.; Ferreira, I.C.F.R.; Soković, M.; van Griensven, L.J.L.D. Chemical characterization and biological activity of Chaga (Inonotus obliquus), a medicinal “mushroom”. J. Ethnopharmacol. 2015, 162, 323–332. [Google Scholar] [CrossRef] [Green Version]
  15. Géry, A.; Dubreule, C.; André, V.; Rioult, J.P.; Bouchart, V.; Heutte, N.; Eldin de Pécoulas, P.; Krivomaz, T.; Garon, D. Chaga (Inonotus obliquus), a Future Potential Medicinal Fungus in Oncology? A Chemical Study and a Comparison of the Cytotoxicity Against Human Lung Adenocarcinoma Cells (A549) and Human Bronchial Epithelial Cells (BEAS-2B). Integr Cancer Ther. 2018, 17, 832–843. [Google Scholar] [CrossRef] [Green Version]
  16. Yang, F.Q.; Li, D.Q.; Feng, K.; Hu, D.J.; Li, S.P. Determination of nucleotides, nucleosides and their transformation products in Cordyceps by ion-pairing reversed-phase liquid chromatography-mass spectrometry. J. Chromatogr. A. 2010, 1217, 5501–5510. [Google Scholar] [CrossRef]
  17. Peng, H.; Shahidi, F. Qualitative Analysis of Secondary Metabolites of Chaga Mushroom (Inonotus obliquus): Phenolics, Fatty Acids, and Terpenoids. J. Food Bioact. 2022, 17, 56–57. [Google Scholar] [CrossRef]
  18. Golianek, A.; Mazurkiewicz-Zapałowicz, K. Mushrooms in the human diet—Nutritional and pro-health value. Kosmos 2016, 65, 513–522. [Google Scholar]
  19. Dimopoulou, M.; Kolonas, A.; Mourtakos, S.; Androutsos, O.; Gortzi, O. Nutritional Composition and Biological Properties of Sixteen Edible Mushroom Species. Appl. Sci. 2022, 12, 8074. [Google Scholar] [CrossRef]
  20. Lu, Y.; Jia, Y.; Xue, Z.; Li, N.; Liu, J.; Chen, H. Recent Developments in Inonotus obliquus (Chaga mushroom) Polysaccharides: Isolation, Structural Characteristics, Biological Activities and Application. Polymers 2021, 13, 1441. [Google Scholar] [CrossRef] [PubMed]
  21. Kyanko, M.V.; Canel, R.S.; Ludemann, V.; Pose, G.; Wagner, J.R. β-Glucan Content and Hydration Properties of Filamentous Fungi. Prikl Biokhim Mikrobiol. 2013, 49, 48–52. [Google Scholar] [CrossRef]
  22. Parepalli, Y.; Chavali, M.; Sami, R.; Khojah, E.; Elhakem, A.; El Askary, A.; Singh, M.; Sinha, S.; El-Chaghaby, G. Evaluation of Some Active Nutrients, Biological Compounds and Health Benefits of Reishi Mushroom (Ganoderma lucidum). Int. J. Pharmacol. 2021, 17, 243–250. [Google Scholar] [CrossRef]
  23. Chaturvedi, V.K.; Agarwal, S.; Gupta, K.K.; Ramteke, P.W.; Singh, M.P. Medicinal Mushroom: Boon for Therapeutic Applications. 3 Biotech 2018, 8, 334. [Google Scholar] [CrossRef] [PubMed]
  24. Martínez-Flores, H.E.; Maya-Cortés, D.C.; Figueroa-Cárdenas, J.D.; Garnica-Romo, M.G.; Ponce-Saavedra, J. Chemical composition and physicochemical properties of shiitake mushroom and high fiber products. J. Food 2009, 7, 7–14. [Google Scholar] [CrossRef]
  25. Riaz, S.; Ahmad, A.; Farooq, R.; Ahmed, M.; Shaheryar, M.; Hussain, M. Edible Mushrooms, a Sustainable Source of Nutrition, Biochemically Active Compounds and Its Effect on Human Health. In Current Topics in Functional Food; IntechOpen: Rijeka, Croatia, 2022. [Google Scholar] [CrossRef]
  26. Antunes, P.S.; Erpen-Dalla Corte, L.; Bueno, J.C.; Spinosa, W.A.; Resende, J.T.V.; Hata, F.T.; Cabrera, L.C.; Zeffa, D.M.; Gonçalves, L.S.; Constantino, L.V. Firmness and biochemical composition of Shitake and Shimeji commercialized in natura and consumers’ opinion survey. Hortic. Bras. 2021, 39, 425–431. [Google Scholar] [CrossRef]
  27. Reguła, J.; Siwulski, M. Dried Shiitake (Lentinula edodes) and Oyster (Pleurotus ostreatus) Mushrooms as a Good Source of Nutrient. Acta Sci. Pol. Technol. Aliment. 2007, 6, 135–142. [Google Scholar]
  28. Kıvrak, I.; Kivrak, S.; Karababa, E. Assessment of Bioactive Compounds and Antioxidant Activity of Turkey Tail Medicinal Mushroom Trametes versicolor (Agaricomycetes). Int. J. Med. Mushrooms 2020, 22, 559–571. [Google Scholar] [CrossRef]
  29. Vetter, J. The Mushroom Glucans: Molecules of High Biological and Medicinal Importance. Foods 2023, 12, 1009. [Google Scholar] [CrossRef]
  30. Valverde, M.E.; Hernandez-Perez, T.; Paredes-Lopez, O. Edible mushroom: Improving human health and promoting quality life. Int. J. Microbiol. 2015, 2015, 376387. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  31. Villares, A.; Mateo-Vivaracho, L.; Guillamón, E. Structural Features and Healthy Properties of Polysaccharides Occurring in Mushrooms. Agriculture 2012, 2, 452–471. [Google Scholar] [CrossRef] [Green Version]
  32. Cerletti, C.; Esposito, S.; Iacoviello, L. Edible Mushrooms and Beta-Glucans: Impact on Human Health. Nutrients 2021, 13, 2195. [Google Scholar] [CrossRef] [PubMed]
  33. Meng, Y.; Lyu, F.; Xu, X.; Zhang, L. Recent advances in chain conformation and bioactivities of triple-helix polysaccharides. Biomacromolecules 2020, 21, 1653–1677. [Google Scholar] [CrossRef]
  34. Rop, O.; Mlcek, J.; Jurikova, T. Beta-glucans in higher fungi and their health effects. Nutr. Rev. 2009, 67, 624–631. [Google Scholar] [CrossRef]
  35. Falch, B.H.; Espevik, T.; Ryan, L.; Stokke, B.T. The cytokine stimulating activity of (1→3)-beta-D-glucans is dependent on the triple helix conformation. Carbohydr. Res. 2000, 329, 587–596. [Google Scholar] [CrossRef] [PubMed]
  36. Sletmoen, M.; Stokke, B.T. Higher order structure of (1,3)-beta-D-glucans and its influence on their biological activities and complexation abilities. Biopolymers 2008, 89, 310–321. [Google Scholar] [CrossRef]
  37. Brown, G.D.; Gordon, S. Fungal beta-glucans and mammalian immunity. Immunity 2003, 19, 311–315. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  38. Nitschke, J.; Modick, H.; Busch, E.; von Rekowski, R.W.; Altenbach, H.J.; Mölleken, H. A New Colorimetric Method to Quantify β-1,3–1,6-Glucans in Comparison with Total β-1,3-Glucans in Edible Mushrooms. Food Chem. 2011, 127, 791–796. [Google Scholar] [CrossRef]
  39. Rasmy, G.E.; Botros, W.A.; Kabeil, S.; Daba, A.S. Preparation of Glucan from Lentinula edodes Edible Mushroom and Elucidation of Its Medicinal Value. Aust. J. Basic Appl. Sci. 2010, 4, 5717–5726. [Google Scholar]
  40. Mirończuk-Chodakowska, I.; Witkowska, A.M. Evaluation of Polish Wild Mushrooms as Beta-Glucan Sources. Int. J. Environ. Res. Public Health 2020, 17, 7299. [Google Scholar] [CrossRef]
  41. Trivedi, S.; Patel, K.; Belgamwar, V.; Wadher, K. Functional polysaccharide lentinan: Role in anti-cancer therapies and management of carcinomas. Pharmacol. Res. Mod. Chin. Med. 2022, 2, 100045. [Google Scholar] [CrossRef]
  42. Wu, J.-Y.; Siu, K.-C.; Geng, P. Bioactive Ingredients and Medicinal Values of Grifola frondosa (Maitake). Foods 2021, 10, 95. [Google Scholar] [CrossRef] [PubMed]
  43. Del Cornò, M.; Gessani, S.; Conti, L. Shaping the Innate Immune Response by Dietary Glucans: Any Role in the Control of Cancer? Cancers 2020, 12, 155. [Google Scholar] [CrossRef] [Green Version]
  44. Song, H.-N. Functional Cordyceps Coffee Containing Cordycepin and β-Glucan Hyo-Nam Song. Prev. Nutr. Food Sci. 2020, 25, 184–193. [Google Scholar] [CrossRef] [PubMed]
  45. Sari, M.; Prange, A.; Lelley, J.I.; Hambitzer, R. Screening of beta-glucan contents in commercially cultivated and wild growing mushrooms. Food Chem. 2017, 216, 45–51. [Google Scholar] [CrossRef]
  46. Yuan, M.; Li, C.; Xiao, X.; Wan, D.; Xi, B.; Jiang, X.; Zhang, J. Effect of lentinan on proliferation and apoptosis of human astrocytoma U251 cells. Pol J Pathol. 2023, 3, 47758. [Google Scholar] [CrossRef] [PubMed]
  47. Ataollahi, H.; Larypoor, M. Fabrication and investigation potential effect of lentinan and docetaxel nanofibers for synergistic treatment of breast cancer in vitro. Polym. Adv. Technol. 2022, 33, 1468–1480. [Google Scholar] [CrossRef]
  48. Wang, Z.; Qu, K.; Zhou, L.; Ren, L.; Ren, B.; Meng, F.; Yu, W.; Wang, H.; Fan, H. Apaf1 NanoLuc biosensors identified lentinan as a potent synergizer of cisplatin in targeting hepatocellular carcinoma cells. Biochem. Biophys. Res. Commun. 2021, 577, 45–51. [Google Scholar] [CrossRef]
  49. Abascal, K.Y.; Yarnell, E. A turkey tail polysaccharide as an immunochemotherapy agent in cancer. Altern. Complement. Ther. 2007, 13, 178–182. [Google Scholar] [CrossRef]
  50. Thuy, D.T.P.; Anh, T.T.N.; Thuy, N.T.T.; Intaparn, P.; Tapingkae, T.; Mai, N.T. Simple and Efficient Method for the Detection and Quantification of Cordycepin Content in Cordyceps. Chiang Mai J. Sci. 2021, 48, 420–428. [Google Scholar]
  51. Karishma, R.; Rachana, M. Potential Secondary Bioactive Compounds of Ganoderma lucidum (Reishi Mushroom) against Various Pathogenic Activity. Pharmacologyonline 2021, 3, 1923–1944. [Google Scholar]
  52. Ahmad, M.F. Ganoderma lucidum: Persuasive biologically active constituents and their health endorsement. Biomed. Pharmacother. 2018, 107, 507–519. [Google Scholar] [CrossRef] [PubMed]
  53. Turło, J. Large-flowered mushrooms—An underestimated source of medicinal substances. Stud. I Mater. CEPL 2015, 17, 138–151. [Google Scholar]
  54. Thongbai, B.; Rapior, S.; Hyde, K.D.; Wittstein, K.; Stadler, M. Hericium erinaceus, an Amazing Medicinal Mushroom. Mycol. Prog. 2015, 14, 91. [Google Scholar] [CrossRef]
  55. Doi, N.; Araki, K.; Fukuta, Y.; Kuwagaito, Y.; Yamauchi, Y.; Sasai, Y.; Kondo, S.; Kuzuya, M. Anti-glycation and antioxidant effects of Chaga mushroom decoction extracted with a fermentation medium. Food Sci. Technol. Res. 2023, 29, 155–161. [Google Scholar] [CrossRef]
  56. Liu, Y.; Wang, J.; Wang, W.; Zhang, H.; Zhang, X.; Han, C. The Chemical Constituents and Pharmacological Actions of Cordyceps sinensis. Evid. Based Complement. Altern. Med. 2015, 2015, 575063. [Google Scholar] [CrossRef] [Green Version]
  57. Wang, M.; Meng, X.Y.; Yang, R.L.; Qin, T.; Wang, X.Y.; Zhang, K.Y.; Fei, C.Z.; Li, Y.; Hu, Y.L.; Xue, F.Q. Cordyceps militaris polysaccharides can enhance the immunity and antioxidation activity in immunosuppressed mice. Carbohydr. Polym. 2012, 89, 461–466. [Google Scholar] [CrossRef]
  58. Zhao, C.S.; Yin, W.T.; Wang, J.Y.; Zhang, Y.; Yu, H.; Cooper, R.; Smidt, C.; Zhu, J.S. CordyMax Cs-4 improves glucose metabolism and increases insulin sensitivity in normal rats. J. Altern. Complement. Med. 2002, 8, 309–314. [Google Scholar] [CrossRef]
  59. Yan, X.-F.; Zhang, Z.-M.; Yao, H.-Y.; Guan, Y.; Zhu, J.-P.; Zhang, L.-H.; Jia, Y.-L.; Wang, R.-W. Cardiovascular protection and antioxidant activity of the extracts from the mycelia of Cordyceps sinensis act partially via adenosine receptors. Phytother. Res. 2013, 27, 1597–1604. [Google Scholar] [CrossRef]
  60. Vetvicka, V.; Vetvickova, J. Immune-Enhancing Effects of Maitake (Grifola frondosa) and Shiitake (Lentinula edodes) Extracts. Ann. Transl. Med. 2014, 2, 14. [Google Scholar] [CrossRef]
  61. Miletić, D.; Turło, J.; Podsadni, P.; Sknepnek, A.; Szczepańska, A.; Lević, S.; Nedović, V.; Nikšić, M. Turkey Tail Medicinal Mushroom, Trametes versicolor (Agaricomycetes), Crude Exopolysaccharides with Antioxidative Activity. Int. J. Med. Mushrooms 2020, 22, 885–895. [Google Scholar] [CrossRef]
  62. Benson, K.F.; Stamets, P.; Davis, R.; Nally, R.; Taylor, A.; Slater, S.; Jensen, G.S. The mycelium of the Trametes versicolor (Turkey tail) mushroom and its fermented substrate each show potent and complementary immune activating properties in vitro. BMC Complement. Altern. Med. 2019, 19, 342. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  63. Landi, N.; Clemente, A.; Pedone, P.V.; Ragucci, S.; Di Maro, A. An Updated Review of Bioactive Peptides from Mushrooms in a Well-Defined Molecular Weight Range. Toxins 2022, 14, 84. [Google Scholar] [CrossRef] [PubMed]
  64. Sousa, A.S.; Araújo-Rodrigues, H.; Pintado, M.E. The health-promoting potential of edible mushroom proteins. Current Pharm. Des. 2023, 29, 804–823. [Google Scholar] [CrossRef]
  65. El-Maradny, Y.A.; El-Fakharany, E.M.; Abu-Serie, M.M.; Hashish, M.H.; Selim, H.S. Lectins purified from medicinal and edible mushrooms: Insights into their antiviral activity against pathogenic viruses. Int. J. Biol. Macromol. 2021, 179, 239–258. [Google Scholar] [CrossRef]
  66. Singh, R.S.; Kaur Preet, H.; Kanwar, J.R. Mushroom lectins as promising anticancer substances. Curr. Protein Pept. Sci. 2016, 17, 797–807. [Google Scholar] [CrossRef]
  67. Li, F.; Wen, H.; Zhang, Y.; Aa, M.; Liu, X. Purification and characterization of a novel immunomodulatory protein from the medicinal mushroom Trametes versicolor. Sci. China Life Sci. 2011, 54, 379–385. [Google Scholar] [CrossRef] [Green Version]
  68. Qi, W.; Zhang, Y.; Yan, Y.B.; Lei, W.; Wu, Z.X.; Liu, N.; Liu, S.; Shi, L.; Fan, Y. The Protective Effect of Cordymin, a Peptide Purified from the Medicinal Mushroom Cordyceps sinensis, on Diabetic Osteopenia in Alloxan-Induced Diabetic Rats. Evid. Based Complement. Alternat. Med. 2013, 2013, 985636. [Google Scholar] [CrossRef] [Green Version]
  69. Thatoi, H.; Singdevsachan, S.K. Diversity, Nutritional Composition and Medicinal Potential of Indian Mushrooms: A Review. Afr. J. Biotechnol. 2014, 13, 523–545. [Google Scholar] [CrossRef]
  70. Pop, R.M.; Puia, I.C.; Puia, A.; Chedea, V.S.; Leopold, N.; Bocsan, I.C.; Buzoianu, A.D. Characterization of Trametes versicolor: Medicinal Mushroom with Important Health Benefits. Not. Bot. Horti Agrobo. 2018, 46, 343–349. [Google Scholar] [CrossRef] [Green Version]
  71. Tagkouli, D.; Kaliora, A.; Bekiaris, G.; Koutrotsios, G.; Christea, M.; Zervakis, G.I.; Kalogeropoulos, N. Free Amino Acids in Three Pleurotus Species Cultivated on Agricultural and Agro-Industrial By-Products. Molecules 2020, 25, 4015. [Google Scholar] [CrossRef]
  72. Guo, L.-X.; Xu, X.-M.; Wu, C.-F.; Lin, L.; Zou, S.-C.; Luan, T.-G.; Yuan, J.-P.; Wang, J.-H. Fatty acid composition of lipids in wild Cordyceps sinensis from major habitats in China. Biomed. Prev. Nutr. 2012, 2, 42–50. [Google Scholar] [CrossRef]
  73. Kim, J.-H.; Hubbard, N.E.; Ziboh, V.; Kelly, L. Erickson. Conjugated Linoleic Acid Reduction of Murine Mammary Tumor Cell Growth through 5-Hydroxyeicosatetraenoic. Acid. Biochim. Biophys. Acta 2005, 1687, 103–109. [Google Scholar] [CrossRef]
  74. Urbain, P.; Singler, F.; Ihorst, G.; Biesalski, H.K.; Bertz, H. Bioavailability of vitamin D2 from UV-B-irradiated button mushrooms in healthy adults deficient in serum 25-hydroxyvitamin D: A randomized controlled trial. Eur. J. Clin. Nutr. 2011, 65, 965–971. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  75. Zheng, J.; Wang, Y.; Wang, J.; Liu, P.; Li, J.; Zhu, W. Antimicrobial Ergosteroids and Pyrrole Derivatives from Halotolerant Aspergillus flocculosus PT05-1 Cultured in a Hypersaline Medium. Extremophiles 2013, 17, 963–971. [Google Scholar] [CrossRef] [PubMed]
  76. Yang, L.-Y.; Huang, W.-J.; Hsieh, H.-G.; Lin, C.-Y. H1-A Extracted from Cordyceps sinensis, Suppresses the Proliferation of Human Mesangial Cells and Promotes Apoptosis, Probably by Inhibiting the Tyrosine Phosphorylation of Bcl-2 and Bcl-XL. J. Lab. Clin. Med. 2003, 141, 74–83. [Google Scholar] [CrossRef]
  77. Ahmed, A.F.; Mahmoud, G.A.-E.; Hefzy, M.; Liu, Z.; Ma, C. Overview on the edible mushrooms in Egypt. J. Future Foods 2023, 3, 8–15. [Google Scholar] [CrossRef]
  78. Sharpe, E.; Farragher-Gnadt, A.; Igbanugo, M.; Huber, T.; Michelotti, J.C.; Milenkowic, A.; Ludlam, S.; Walker, M.; Hanes, D.; Bradley, R.; et al. Comparison of Antioxidant Activity and Extraction Techniques for Commercially and Laboratory Prepared Extracts from Six Mushroom Species. J. Agric. Food Res. 2021, 4, 100130. [Google Scholar] [CrossRef]
  79. Das, A.K.; Nanda, P.K.; Dandapat, P.; Bandyopadhyay, S.; Gullón, P.; Sivaraman, G.K.; McClements, D.J.; Gullón, B.; Lorenzo, J.M. Edible Mushrooms as Functional Ingredients for Development of Healthier and More Sustainable Muscle Foods: A Flexitarian Approach. Molecules 2021, 26, 2463. [Google Scholar] [CrossRef]
  80. Podkowa, A.; Kryczyk-Poprawa, A.; Opoka, W.; Kozarski, M.; Wróbel, M.S. Culinary–Medicinal Mushrooms: A Review of Organic Compounds and Bioelements with Antioxidant Activity. Eur. Food Res. Technol. 2021, 247, 513–533. [Google Scholar] [CrossRef]
  81. Ma, G.; Yang, W.; Zhao, L.; Pei, F.; Fang, D.; Hu, Q. A critical review on the health promoting effects of mushrooms nutraceuticals. Food Sci. Hum. Wellness 2018, 7, 125–133. [Google Scholar] [CrossRef]
  82. Taşkın, H.; Süfer, Ö.; Attar, S.H.; Kılıç, Ö.; Güzel, M.; Atakol, O. Total Phenolics, Antioxidant Activities and Fatty Acid Profiles of Six Morchella Species. J. Food Sci. Technol. 2021, 58, 692–700. [Google Scholar] [CrossRef] [PubMed]
  83. Saltarelli, R.; Palma, F.; Gioacchini, A.M.; Bucchini, A.; Chiarini, A.; Pellegrini, A.; Rocchi, M.B.L.; Stocchi, V. Phytochemical Composition, Antioxidant and Antiproliferative Activities and Effects on Nuclear DNA of Ethanolic Extract from an Italian Mycelial Isolate of Ganoderma lucidum. J. Ethnopharmacol. 2019, 231, 464–473. [Google Scholar] [CrossRef] [PubMed]
  84. Van, Q.; Nayak, B.N.; Reimer, M.; Jones, P.J.H.; Fulcher, R.G.; Rempel, C.B. Anti-inflammatory effect of Inonotus obliquus, Polygala senega L.; and Viburnum trilobum in a cell screening assay. J. Ethnopharmacol. 2009, 125, 487–493. [Google Scholar] [CrossRef] [PubMed]
  85. Akihisa, T.; Nakamura, Y.; Tagata, M.; Tokuda, H.; Yasukawa, K.; Uchiyama, E.; Suzuki, T.; Kimura, Y. Anti-Inflammatory and Anti-Tumor-Promoting Effects of Triterpene Acids and Sterols from the Fungus Ganoderma lucidum. Chem. Biodivers. 2007, 4, 105–255. [Google Scholar] [CrossRef]
  86. Wang, S.; Bao, L.; Zhao, F.; Wang, Q.; Li, S.; Ren, J.; Li, L.; Wen, H.; Guo, L. Isolation, Identification, and Bioactivity of Monoterpenoids and Sesquiterpenoids from the Mycelia of Edible Mushroom Pleurotus cornucopiae. J. Agric. Food Chem. 2013, 61, 5122–5129. [Google Scholar] [CrossRef]
  87. Dasgupta, A.; Acharya, K. Mushrooms: An Emerging Resource for Therapeutic Terpenoids. 3 Biotech. 2019, 9, 369. [Google Scholar] [CrossRef]
  88. Zhang, X.; Zhang, S.; Yang, Y.; Wang, D.; Gao, H. Natural barrigenol-like triterpenoids: A comprehensive review of their contributions to medicinal chemistry. Phytochemistry 2019, 161, 41–74. [Google Scholar] [CrossRef]
  89. Teichmann, A.; Dutta, P.C.; Staffas, A.; Jägerstad, M. Sterol and vitamin D2 concentrations in cultivated and wild grown mushrooms: Effects of UV irradiation. LWT Food Sci. Technol. 2007, 40, 815–822. [Google Scholar] [CrossRef]
  90. Feeney, M.J.; Dwyer, J.; Hasler-Lewis, C.M.; Milner, J.A.; Noakes, M.; Rowe, S.; Wach, M.; Beelman, R.B.; Caldwell, J.; Cantorna, M.T.; et al. Mushrooms and Health Summit Proceedings. J. Nutr. 2014, 144, 1128S–1136S. [Google Scholar] [CrossRef] [Green Version]
  91. Gründemann, C.; Reinhardt, J.K.; Lindequist, U. European medicinal mushrooms: Do they have potential for modern medicine?–An update. Phytomedicine 2020, 66, 153131. [Google Scholar] [CrossRef]
  92. Waktola, G.; Temesgen, T. Application of Mushroom as Food and Medicine. Adv. Biotechnol. Microbiol. 2018, 11, 555817. [Google Scholar] [CrossRef]
  93. Sachdeva, V.; Roy, A.; Bharadvaja, N. Current Prospects of Nutraceuticals: A Review. Curr. Pharm. Biotechnol. 2020, 21, 884–896. [Google Scholar] [CrossRef] [PubMed]
  94. Benkeblia, N. Polysaccharides Natural Fibres in Food and Nutrition; CRC Press: Boca Raton, FL, USA, 2014. [Google Scholar] [CrossRef]
  95. Rathore, H.; Prasad, S.; Sharma, S. Mushroom Nutraceuticals for Improved Nutrition and Better Human Health: A Review. PharmaNutrition 2017, 5, 35–46. [Google Scholar] [CrossRef]
  96. Krzystyniak, K.L.; Klonowska, J. New Trends in Dietetics; University of Engineering and Health: Warsaw, Poland, 2019; p. 27. ISBN 978-83-942432-4-1. [Google Scholar]
  97. Lu, X.; Brennan, M.A.; Serventi, L.; Brennan, C.S. Incorporation of Mushroom Powder into Bread Dough—Effects on Dough Rheology and Bread Properties. Cereal Chem. 2018, 95, 418–427. [Google Scholar] [CrossRef]
  98. Wannasupchue, W.; Siriamornpun, S.; Huaisan, K.; Huaisan, J.; Meeso, N. Effect of Adding Ling-zhi (Ganoderma lucidum) on Oxidative Stability, Textural and Sensory Properties of Smoked Fish Sausage. Thai J. Agric. Sci. 2011, 44, 505–512. [Google Scholar]
  99. Leskosek-Cukalovic, I.; Despotovic, S.; Lakic, N.; Niksic, M.; Nedovic, V.; Tesevic, V. Ganoderma lucidum—Medical Mushroom as a Raw Material for Beer with Enhanced Functional Properties. Food Res. Int. 2010, 43, 2262–2269. [Google Scholar] [CrossRef]
  100. Ghobadi, R.; Mohammadi, R.; Chabavizade, J.; Sami, M. Effect of Ganoderma lucidum Powder on Oxidative Stability, Microbial and Sensory Properties of Emulsion Type Sausage. Adv. Biomed. Res. 2018, 7, 135. [Google Scholar] [CrossRef]
  101. Chung, H.C.; Lee, J.T.; Kwon, O.J. Bread Properties Utilizing Extracts of Ganoderma lucidum (GL). J. Korean Soc. Food Sci. Nutr. 2004, 33, 1201–1205. [Google Scholar] [CrossRef] [Green Version]
  102. Jovanović, M.; Vojvodić, P.; Petrović, M.; Radić, D.; Mitić-Ćulafić, D.; Kostić, M.; Veljović, S. Yogurt Fortified with GABA-Producing Strain and Ganoderma lucidum Industrial Waste. Czech J. Food Sci. 2022, 40, 456–464. [Google Scholar] [CrossRef]
  103. Szydłowska-Tutaj, M.; Szymanowska, U.; Tutaj, K.; Domagała, D.; Złotek, U. The Addition of Reishi and Lion’s Mane Mushroom Powder to Pasta Influences the Content of Bioactive Compounds and the Antioxidant, Potential Anti-Inflammatory, and Anticancer Properties of Pasta. Antioxidants 2023, 12, 738. [Google Scholar] [CrossRef]
  104. Singh, J.; Sindhu, S.C.; Sindhu, A.; Yadav, A. Development and Evaluation of Value Added Biscuits from Dehydrated Shiitake (Lentinus edodes) Mushroom. Int. J. Curr. Res. 2016, 8, 27155–27159. [Google Scholar]
  105. Chun, S.; Chambers, E., IV.; Chambers, D. Perception of Pork Patties with Shiitake (Lentinus edodes) Mushroom Powder and Sodium Tripolyphosphate as Measured by Korean and United States Consumers. J. Sens. Stud. 2005, 20, 156–166. [Google Scholar] [CrossRef]
  106. Lu, X.; Brennan, M.A.; Serventi, L.; Mason, S.; Brennan, C.S. How the Inclusion of Mushroom Powder Can Affect the Physicochemical Characteristics of Pasta. Int. J. Food Sci. Technol. 2016, 51, 2433–2439. [Google Scholar] [CrossRef]
Table
Table 1. The chemical composition of medicinal mushrooms (g/100 g dried mushrooms).
Table 1. The chemical composition of medicinal mushrooms (g/100 g dried mushrooms).
Common
Name		Latin Name MoistureProteinCarbohydratesLipidsDietary FibreAshThe Literature Source
ReishiGanoderma lucidum (Curtis) P. Karst.7.5–12.9913.3–23.642.8–82.33–5.814.814[19,22,23]
Lion’s ManeHericium erinaceus (Bull.) Pers.7.03 *22.357.03.53.3–7.87.1[19,23]
ChagaInonotus obliquus (Ach. ex Pers.) Pilát3.52.410.31.767.5n.d.[20]
CordycepsOphiocordyceps sinensis (Berk.) G.H. Sung, J.M. Sung, Hywel-Jones and Spataforaprior name Cordyceps sinensis3.5 *21.9–23.124.2–49.35.5–8.27.713.13[19,23]
ShiitakeLentinula edodes (Berk.) Pegler7.1417.2–27.0938.1–66.01.26–2.9546.19–49.09 (IDF: 40.7–44.2 and SDF: 1.95–8.4) 6.05–6.73[24,25,26,27]
Turkey Tail
It also known as:,
Cloud mushroom,
Yun Zhi, Kawaritake		Trametes versicolor (L.) Lloyd-11.07-1.35--[28]
(-)—no data; (*)—unpublished own research, IDF—water-insoluble dietary fibre, SDF—water-soluble dietary fibre.
Table
Table 2. Beta-glucan content of different medicinal mushrooms [31,44,48].
Table 2. Beta-glucan content of different medicinal mushrooms [31,44,48].
Common NameLatin NameContent of β-Glucans
(g/100 g d.b.)
ReishiGanoderma lucidum (Curtis) P. Karst.4.3–23.6
Lion’s ManeHericium erinaceus (Bull.) Pers.35.3
ChagaInonotus obliquus (Ach. ex Pers.) Pilát8.5
Shiitake cap/steamLentinula edodes (Berk.) Pegler20.0/25.3
Turkey tailTrametes versicolor (L.) Lloyd60.79
CordycepsOphiocordyceps sinensis (Berk.) G.H. Sung, J.M. Sung, Hywel-Jones and Spatafora prior name Cordyceps sinensis3.79
Table
Table 3. Bioactive components in medicinal mushrooms and their health-promoting effects.
Table 3. Bioactive components in medicinal mushrooms and their health-promoting effects.
Common
Name		Latin NameCompounds with Bioactive PotentialHealth-Promoting EffectsReferences
ReishiGanoderma lucidum (Curtis) P. Karst.Polysaccharides
Glycoproteins (lectins) Phenols
Steroids
Triterpenoids
Nucleotides
Fatty acids
Vitamins
Minerals		Anti-inflammatory Anticancer
Antiviral (including HIV)
Antimicrobial
Hypotensive effect Cardiotonic Immunomodelling Nephrotonic Hepatoprotective Neurotonic
Anti-asthmatic		[21] a, [51], [52] a,b, [53]
Lion’s ManeHericium erinaceus (Bull.) Pers.Hericerins,
Erinacins,
Glycoprotein, Polysaccharides
Beta-glucans,
Sterols,
Lactone,
Fatty acids
Volatile compounds (e.g., hexadecanoic acid, linoleic acid, phenylacetaldehyde, benzaldehyde) 		Anticancer, Antioxidant,
Anti-ageing, Imunomodelling, Neurotonic,
Anti-asmatic,
Hypoglycemic effects
Hypocholesterolemic effects		[46] a,b, [53], [54] a,b
ChagaInonotus obliquus (Ach. ex Pers.) PilátPolysaccharides
Fatty acids
Hydroxy acids
Poliphenols (phenolic acids, flavonoids, coumarins, quinones, and styrylpyrones)
Triterpenoids (lanosterol)
Steroids (ergosterol and ergosterol peroxide)		Antioxidant,
Anti-ageing, Antimicrobial activity,
Antitumor activity, Anti-inflammatory hypoglycemic effect, Antilipidemic effect, Antiglication effect,
Immunoregulatory Cardioprotective effects		[14] b, [17,54,55]
CordycepsOphiocordyceps sinensis (Berk.) G.H. Sung, J.M. Sung, Hywel-Jones & Spatafora prior name Cordyceps sinensisCordycepin (purine alkaloid)
Cordymin (peptide)
Adenosine
Cordycepic acid (d-mannitol)
Trehalose
Polysaccharide
Beta-glucans
Saponins
Polyunsaturated fatty acids, Ergosterol
δ-tocopherol Hydroxybenzoic acid		Antitumor, Hypoglycemic effect
Hypocholesterolemic effect,
Anti-inflammatory, Antioxidant, Antiaging activity, Antimicrobial activity, Anticonvulsant activity, Cardiovascular protection
(reduces cardiac arrhythmia and chronic heart failure)		[49], [56] ab, [57] a, [58] a, [59] a
ShiitakeLentinula edodes (Berk.) PeglerPolysaccharides,
Beta-glucans (lentinan)
Glycoproteins,
Phenols,
Steroids,
Terpenoids,
Nucleotides 		Immune-enhancing
effects,
Antitumor,
Antioxidant, Antiaging activity,
Antimicrobial activity,
Hypocholesterolemic effect,
Reduction in blood pressure		[26], [27] a, [60]
Turkey Tail
It also known as:
Cloud mushroom,
Yun Zhi, Kawaritake		Trametes versicolor (L.) LloydPolysaccharopeptide (PSP) and polysaccharide K (PSK)
(1,3)(1,6)-β-d-glucans,
Poliphenols (phenolic acids: p-hydroxy benzoic, protocatechuic, vanillic, and homogentisic),
Vitamin B,
Fatty acids (linoleic, oleic, stearic, linolenic)		Antitumor
Immunoregulatory,
Antioxidant activity
Prevent obesity,
Antimicrobial,
Antidiabetic
AChE inhibitorY		[28,61], [62] b
a—in vivo studies. b—in vitro studies.
Table
Table 4. Use of medicinal mushrooms for food enrichment.
Table 4. Use of medicinal mushrooms for food enrichment.
Common NameLatin NameProduct/
Size of Additive		Impact on Chemical Composition
(~) Lack of Impact
(↓) Decrease
(↑) Increase		Impact on Quality ParametersReferences
ReishiGanoderma lucidum (Curtis) P. Karst.Smoked fish sausage
1% of crushed mushroom		(↑) Antioxidant properties
(↑) Total phenol content: +
(↓)Moisture: −
(↑) Ash: +
(↑) Protein: +
(↓)Fat: −
Fiber: +		(↑) Shelf life
(↓) Texture
Sensory evaluation: (↓) flavour,
(↓) colour,
(↓) taste,
(↓) texture,
(↓) appearance,
(↓) overall 		[98]
1% of water extract(↑) Antioxidant properties
(↑) Total phenol content
(↓) Moisture: −
(↑) Ash
(↓) Protein: −
(~) Fat
(↑) Fiber: +		(↑) Shelf life
(↑) Texture -
Sensory evaluation: (↑) flavour,
(↑) colour,
(↑) taste,
(↑) texture,
(~) appearance, (↑) overall
0.25% of spore(↑) Antioxidant properties
(↑) Total phenol content
(↓) Moisture: −
(↑) Ash
(↑) Protein
(↑) Fat
(↓) Fiber		(↑) Shelf life
(~) Texture
Sensory evaluation: (↓) flavour,
(↓) colour,
(↓) taste,
(↓) texture,
(~) appearance,
(↓) overall
ReishiGanoderma lucidum (Curtis) P. Karst.Pilzner beer
0.1–1.5 mL/L of alcohol extract		 Sensory evaluation:
(~) aroma
(↑) taste
(↑) body
(↑) bitterness
(↑) liveliness
(↑) overall impression		[99]
Reishi Ganoderma lucidum (Curtis) P. Karst.Emulsion Type Sausage
1% of dried fruiting bodies		(↑) Antioxidant properties Sensory evaluation:
(~) texture −
(↓) taste
(↓) Colour −
(↓) Smell
(↓) Acceptability

(~) Peroxide value

(↑) Microbiological analysis +		[100]
ReishiGanoderma lucidum (Curtis) P. Karst.Bread
2/4/6/8% water extract 		(↑) Baking loss
(↓) Bitterness
Sensory evaluation: (↑) 2–4%,
(↓) 6–8%
Texture:
(~) 2–4%
(↓) 6–8% −		[101]
ReishiGanoderma lucidum (Curtis) P. Karst. Yoghurt
2% Industrial waste (residues from aqueous extraction)		(↑) anti-coli effect,
(↑) against E. coli		(↓) Texture
(↓) Taste		[102]
ReishiGanoderma lucidum (Curtis) P. Karst.Semolina pasta enriched with 2.5 and 5% of mushroom powder(~) Phenolic compounds
(↑) ABTS antiradical properties
(↑) Syringic acid
(~) β-glucan content
(~) Anticancer properties		Not analyzed[103]
Lion’s ManeHericium erinaceus (Bull.) Pers.Semolina pasta enriched with 2.5 and 5% of mushroom powder (~) Phenolic compounds
(~) Antioxidant properties
(~) ABTS antiradical properties
(↑) Vanilin
(~) β-glucan content
(~) Anticancer properties		Not analyzed[103]
ShiitakeLentinula edodes (Berk.) PeglerBiscuits with mushroom powder 10% (↑) Protein
(↑) Mineral (Fe, P, Zn, Ca)
(↑) Total and insoluble dietary fibre 		Sensory evaluation: (~) aroma,
(~) colour,
(~) texture,
(~) shelf life		[104]
ShiitakeLentinula edodes (Berk.) PeglerBread enriched with 5–15% addition of mushroom powder (↑) Dietary fiber Bread dough:
(↑) water absorption;
(↓) development time;
(↓) stability;
>5% decreased the dough strength

Bread quality physical:
(↓) loaf height;
(↑) moisture content;
(↓) specific volume;
>5% (↑) bread’s gumminess;
>5% bread’s (↑) hardness;
(↓) porosity		[97]
Pork patties

0–6% addition to mushroom powder		Not analyzed(↑) texture +;
(↑) juiciness +;
(↑) moisture +		[105]
Semolina pasta enriched with 5–15% addition of mushroom powderNot analyzed(↑) Cooking loss
(~) Water absorption;
(~) Moisture content;
(~) Tensile strength;
(↑) Firmness		[106]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Łysakowska, P.; Sobota, A.; Wirkijowska, A. Medicinal Mushrooms: Their Bioactive Components, Nutritional Value and Application in Functional Food Production—A Review. Molecules 2023, 28, 5393. https://doi.org/10.3390/molecules28145393

AMA Style

Łysakowska P, Sobota A, Wirkijowska A. Medicinal Mushrooms: Their Bioactive Components, Nutritional Value and Application in Functional Food Production—A Review. Molecules. 2023; 28(14):5393. https://doi.org/10.3390/molecules28145393

Chicago/Turabian Style

Łysakowska, Paulina, Aldona Sobota, and Anna Wirkijowska. 2023. "Medicinal Mushrooms: Their Bioactive Components, Nutritional Value and Application in Functional Food Production—A Review" Molecules 28, no. 14: 5393. https://doi.org/10.3390/molecules28145393

APA Style

Łysakowska, P., Sobota, A., & Wirkijowska, A. (2023). Medicinal Mushrooms: Their Bioactive Components, Nutritional Value and Application in Functional Food Production—A Review. Molecules, 28(14), 5393. https://doi.org/10.3390/molecules28145393

Article Metrics

Back to TopTop